These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8847748)

  • 1. Melatonin potentially useful but safety, efficacy remain uncertain.
    Lamberg L
    JAMA; 1996 Oct; 276(13):1011-4. PubMed ID: 8847748
    [No Abstract]   [Full Text] [Related]  

  • 2. Melatonin--to sleep, perchance to dream.
    Powers JE; Kees M
    S D J Med; 1996 May; 49(5):164-5. PubMed ID: 8936019
    [No Abstract]   [Full Text] [Related]  

  • 3. "Macbeth does murder sleep". The mysterious mythic melatonin morass.
    Mack RB
    N C Med J; 1996; 57(3):162-4. PubMed ID: 8935364
    [No Abstract]   [Full Text] [Related]  

  • 4. [Melatonin--a natural hypnotic?].
    Saletu B
    Wien Klin Wochenschr; 1997 Oct; 109(18):714-21. PubMed ID: 9441514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin and its receptors: a new class of sleep-promoting agents.
    Doghramji K
    J Clin Sleep Med; 2007 Aug; 3(5 Suppl):S17-23. PubMed ID: 17824497
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for prescribing melatonin.
    Avery D; Lenz M; Landis C
    Ann Med; 1998 Feb; 30(1):122-30. PubMed ID: 9556099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melatonin receptor agonist].
    Uchiyama M
    Nihon Rinsho; 2015 Jun; 73(6):1017-22. PubMed ID: 26065135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin for the treatment of disorders in circadian rhythm and sleep: could it form a basis for medication?
    Nir I
    Recept Channels; 2003; 9(6):379-85. PubMed ID: 14698965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical perspectives for melatonin and its agonists.
    Arendt J
    Biol Psychiatry; 1994 Jan; 35(1):1-2. PubMed ID: 8167197
    [No Abstract]   [Full Text] [Related]  

  • 10. Melatonin.
    Med Lett Drugs Ther; 1995 Nov; 37(962):111-2. PubMed ID: 7476672
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential action of melatonin in insomnia.
    Rogers NL; Dinges DF; Kennaway DJ; Dawson D
    Sleep; 2003 Dec; 26(8):1058-9. PubMed ID: 14746391
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementary and alternative medicines patients are talking about: melatonin.
    Lee CO
    Clin J Oncol Nurs; 2006 Feb; 10(1):105-7. PubMed ID: 16482735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let there be sleep--on time.
    Cardinali DP; Golombek DA
    Lancet; 2009 Feb; 373(9662):439-41. PubMed ID: 19054553
    [No Abstract]   [Full Text] [Related]  

  • 14. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.
    Rajaratnam SM; Polymeropoulos MH; Fisher DM; Roth T; Scott C; Birznieks G; Klerman EB
    Lancet; 2009 Feb; 373(9662):482-91. PubMed ID: 19054552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.
    Tjon Pian Gi CV; Broeren JPA; Starreveld JS; A Versteegh FG
    Eur J Pediatr; 2003 Jul; 162(7-8):554-555. PubMed ID: 12783318
    [No Abstract]   [Full Text] [Related]  

  • 16. Melatonin decreases daytime challenging behaviour in persons with intellectual disability and chronic insomnia.
    Braam W; Didden R; Maas AP; Korzilius H; Smits MG; Curfs LM
    J Intellect Disabil Res; 2010 Jan; 54(1):52-9. PubMed ID: 19888921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disturbed sleep in children with ADHD: is there a place for melatonin as a treatment option?].
    Holvoet E; Gabriëls L
    Tijdschr Psychiatr; 2013; 55(5):349-57. PubMed ID: 23696337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin: aeromedical, toxicopharmacological, and analytical aspects.
    Sanders DC; Chaturvedi AK; Hordinsky JR
    J Anal Toxicol; 1999; 23(3):159-67. PubMed ID: 10369324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
    Hardeland R
    Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.